Post-operative outcome & disease-free survival among patients of breast cancer with raised C - reactive protein
Background: Cancer and inflammation have a bidirectional association; chronic inflammation is considered a major contributor to carcinogenesis. C - reactive protein (CRP), an inflammatory protein produced by the liver, has been identified as an important prognostic marker among breast cancer patients. This study aimed to elucidate the role of C-reactive protein as an inflammatory prognostic predictor in breast cancer patients and its impact on disease-free survival (DFS).
Methodology: This prospective cohort study included 80 locally advanced breast cancer (stage II and III) patients presenting at the Department of General Surgery (Unit II), Liaquat University Hospital - Jamshoro/Hyderabad. Patient data, including demographics, stage and hormone status of breast cancer, metastatic workup, pre-operative CRP, post-operative complications and DFS on follow-ups including recurrence, metastasis and post-surgery skin manifestation, were recorded using a structured questionnaire. The statistical analysis was conducted on SPSS version 22.0.
Results: Pre-operatively, a mildly raised serum CRP level was observed in 71.25% of patients and highly raised in 28.5%. The post-operative complications were observed in 12 participants with wound infection in 8, wound dehiscence in 3 and sepsis in only 1 participant. The DFS, including recurrence-free and metastatic-free survival, were observed in 69 participants
Conclusion: After thorough observation, it can be concluded that the raised CRP level is a significant predictor for post-operative complications (wound infection, dehiscence, and sepsis) and disease-free survival among patients with locally advanced breast cancer.
2. Ghoncheh M PZ, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;17:43‐46.
3. MO K. The necessity of awareness of breast cancer amongst women in Pakistan. J Pak Med Assoc. 2009; 59(11): 804.
4. Shimura T, Shibata M, Gonda K, Murakami Y, Noda M, Tachibana K, Abe N, Ohtake T. Prognostic impact of interleukin‑6 and C‑reactive protein on patients with breast cancer. Oncol Lett. 2019; 17(6): 5139-5146.
5. Asegaonkar SB, Asegaonkar BN, Takalkar UV, Advani S, Thorat AP. C-Reactive Protein and Breast Cancer: New Insights from Old Molecule. Int J Breast Cancer. 2015;2015:145647.